DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or ...

For patients with moderate Dupuytren contracture, collagenase injection is not noninferior to limited fasciectomy, according to a study published online Oct. 9 in the New England Journal of Medicine.

This marks the first live procedure at AAHS, as well as a first for Keenova. Treatment takes place over two days of annual meeting—injection on Wednesday and finger extension on Friday. Audience of ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.